CN101132785A - 与次卤酸联用的n-卤代氨基酸和n,n-二卤代氨基酸 - Google Patents

与次卤酸联用的n-卤代氨基酸和n,n-二卤代氨基酸 Download PDF

Info

Publication number
CN101132785A
CN101132785A CNA2006800070563A CN200680007056A CN101132785A CN 101132785 A CN101132785 A CN 101132785A CN A2006800070563 A CNA2006800070563 A CN A2006800070563A CN 200680007056 A CN200680007056 A CN 200680007056A CN 101132785 A CN101132785 A CN 101132785A
Authority
CN
China
Prior art keywords
acid
group
composition
hydrogen
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800070563A
Other languages
English (en)
Chinese (zh)
Inventor
拉明·纳杰菲
曼苏尔·巴西里
王露
贝赫扎德·霍斯罗维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novabay Pharmaceuticals Inc
Original Assignee
Novabay Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novabay Pharmaceuticals Inc filed Critical Novabay Pharmaceuticals Inc
Publication of CN101132785A publication Critical patent/CN101132785A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA2006800070563A 2005-01-25 2006-01-25 与次卤酸联用的n-卤代氨基酸和n,n-二卤代氨基酸 Pending CN101132785A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64736605P 2005-01-25 2005-01-25
US60/647,366 2005-01-25

Publications (1)

Publication Number Publication Date
CN101132785A true CN101132785A (zh) 2008-02-27

Family

ID=36441417

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800070563A Pending CN101132785A (zh) 2005-01-25 2006-01-25 与次卤酸联用的n-卤代氨基酸和n,n-二卤代氨基酸

Country Status (14)

Country Link
US (1) US7846971B2 (enExample)
EP (1) EP1896001B1 (enExample)
JP (1) JP5329095B2 (enExample)
KR (1) KR20070098947A (enExample)
CN (1) CN101132785A (enExample)
AU (1) AU2006208046B2 (enExample)
BR (1) BRPI0607302A2 (enExample)
CA (1) CA2595889C (enExample)
ES (1) ES2421157T3 (enExample)
IL (1) IL184771A (enExample)
MX (1) MX2007008928A (enExample)
TW (1) TWI386201B (enExample)
WO (1) WO2006081392A1 (enExample)
ZA (1) ZA200706402B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102176818A (zh) * 2008-08-12 2011-09-07 诺华贝制药公司 抗微生物凝胶制剂
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0413660A (pt) 2003-08-18 2006-10-24 Novacal Pharmaceuticals Inc Aminoácidos n,n-di-alogenado e derivados
US8747882B2 (en) * 2005-04-21 2014-06-10 Astra Tech Ab Catheter assembly with bactericidal effect
US20090221989A1 (en) * 2005-09-21 2009-09-03 Novabay Pharmaceuticals Inc System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid composition
EP1948154A1 (en) * 2005-10-06 2008-07-30 Novabay Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids
TW200843787A (en) * 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
WO2008094664A1 (en) * 2007-01-31 2008-08-07 Adam Heller Methods and compositions for the treatment of pain
UY31056A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Fromulaciones aminocido n-halogenado y metodos de limpieza y desinfeccion
UY31059A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado
UY31057A1 (es) 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado que contiene acido alifatico
UY31058A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
UY31055A1 (es) * 2008-02-01 2008-10-31 Alcon Res Ltd Sales antimicrobianas de aminoacido n-halogenado
WO2009126912A1 (en) 2008-04-10 2009-10-15 Novabay Pharmaceuticals, Inc. Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
US20110091570A1 (en) * 2008-04-15 2011-04-21 Waldemar Gottardi Compositions and Devices for Antisepsis and Anticoagulation
IL192262A (en) * 2008-06-17 2016-05-31 Z H T Eng Equipment And Tech Ltd A polymer that releases drugs into the animal body, a medicinal product containing it and a method for its preparation
WO2010017405A1 (en) * 2008-08-06 2010-02-11 Adam Heller Methods and compositions for the treatment of pain
US8764638B2 (en) 2008-10-17 2014-07-01 Al Medical Devices, Inc. Endotracheal intubation device
WO2010054269A1 (en) * 2008-11-07 2010-05-14 Novabay Pharmaceuticals, Inc. Antimicrobial n-chlorinated compositions
CA2741660A1 (en) * 2008-11-07 2010-05-14 Novabay Pharmaceuticals, Inc. Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
WO2010091280A1 (en) 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
EP2408740B1 (en) * 2009-03-18 2013-11-20 Olatec Industries LLC Compounds for treating inflammation and pain
US20100272783A1 (en) * 2009-04-24 2010-10-28 Novabay Pharmaceuticals, Inc. Methods of Treating Infections of the Nail
WO2011014460A1 (en) * 2009-07-27 2011-02-03 Novabay Pharmaceuticals, Inc. Methods of treating infections of the nail or skin using hypohalite
SG182621A1 (en) * 2010-02-04 2012-08-30 Novabay Pharmaceuticals Inc Polysaccharide based antimicrobial formulations
US9888832B2 (en) 2010-09-24 2018-02-13 Blink Device LLC Endotracheal intubation device
TWI407907B (zh) * 2010-10-04 2013-09-11 Far Eastern New Century Corp An antibacterial agent with water solubility and biodegradability
WO2012172071A2 (en) 2011-06-15 2012-12-20 Orasolv Ab Detection and removal of carious dentin tissue.
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
US11814739B2 (en) 2016-06-09 2023-11-14 De Nora Holdings Us, Inc. Electrolytic production of organic chloramine solutions
WO2019152233A1 (en) * 2018-01-30 2019-08-08 Buckman Laboratories International, Inc. Synergistic combinations of monochloramine and organic acid, and methods of using the same for microbial control
US12251486B2 (en) 2021-09-09 2025-03-18 Toyota Motor North America, Inc. Vehicle sanitizing systems and methods for using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998945A (en) * 1972-06-12 1976-12-21 National Patent Development Corporation Dental treatment
US4015008A (en) 1974-02-01 1977-03-29 National Patent Development Corporation N,N-dichloro substituted aminocarboxylic acids as microbiocides
US3950536A (en) 1974-02-01 1976-04-13 Sol Joseph Barer N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides
US4045578A (en) 1974-06-14 1977-08-30 Interx Research Corporation N-chloro-amino acid derivatives exhibiting antibacterial activity
US3966796A (en) 1974-06-14 1976-06-29 Interx Research Corporation N-chloro-amino acid derivatives activity
US4386103A (en) 1981-01-30 1983-05-31 Merck & Co., Inc. Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents
US5096700A (en) 1990-09-28 1992-03-17 The Procter & Gamble Company Halogenated aminohexanoates and aminobutyrates antimicrobial agents
DE4041703C2 (de) 1990-12-24 1993-10-21 Waldemar Dr Gottardi Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung
JP3759757B2 (ja) * 1994-01-13 2006-03-29 相互薬工株式会社 殺菌剤
US5753701A (en) 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
DE19712565A1 (de) * 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
DE19816102C1 (de) * 1998-04-10 1999-09-16 Waldemar Gottardi Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen
CA2320556A1 (en) 1999-09-29 2001-03-29 Queen's University At Kingston N,n-dichlorinated omega amino acids and uses thereof
ATE344662T1 (de) 2000-09-14 2006-11-15 Waldemar Gottardi Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
FR2819723B1 (fr) * 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
AU2003279905A1 (en) * 2002-06-27 2004-01-19 Nicholas L. Geranio Integrated property database and search engine
BRPI0413660A (pt) 2003-08-18 2006-10-24 Novacal Pharmaceuticals Inc Aminoácidos n,n-di-alogenado e derivados
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102176818A (zh) * 2008-08-12 2011-09-07 诺华贝制药公司 抗微生物凝胶制剂
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Also Published As

Publication number Publication date
TW200640445A (en) 2006-12-01
CA2595889C (en) 2013-11-19
JP5329095B2 (ja) 2013-10-30
EP1896001B1 (en) 2013-06-19
TWI386201B (zh) 2013-02-21
AU2006208046A1 (en) 2006-08-03
US20060247209A1 (en) 2006-11-02
US7846971B2 (en) 2010-12-07
WO2006081392A1 (en) 2006-08-03
IL184771A (en) 2013-04-30
IL184771A0 (en) 2007-12-03
EP1896001A1 (en) 2008-03-12
BRPI0607302A2 (pt) 2009-08-25
CA2595889A1 (en) 2006-08-03
AU2006208046A2 (en) 2006-08-03
KR20070098947A (ko) 2007-10-05
AU2006208046B2 (en) 2011-03-24
ES2421157T3 (es) 2013-08-29
ZA200706402B (en) 2011-12-28
JP2008531479A (ja) 2008-08-14
MX2007008928A (es) 2007-12-10

Similar Documents

Publication Publication Date Title
CN101132785A (zh) 与次卤酸联用的n-卤代氨基酸和n,n-二卤代氨基酸
CN1902158B (zh) N,n-二卤代氨基酸及其衍生物
US11653653B2 (en) Stable compositions of uncomplexed iodine and methods of use
TW200843787A (en) N-halogenated amino compounds and derivatives; compositions and methods of using them
HK1117748A (en) N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids
HK1103713B (en) N,n-dihalogenated amino acids and derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1117748

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20080227

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1117748

Country of ref document: HK